NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Alphabet-C
GOOG
US Stock MarketDetailed Quotes
SAGE Sage Therapeutics
- 5.610
- +0.610+12.20%
Close Dec 20 16:00 ET
- 5.540
- -0.070-1.25%
Post 20:01 ET
343.18MMarket Cap-1.01P/E (TTM)
5.620High4.950Low4.34MVolume5.060Open5.000Pre Close24.03MTurnover8.97%Turnover RatioLossP/E (Static)61.17MShares28.26052wk High0.62P/B271.25MFloat Cap4.62052wk Low--Dividend TTM48.35MShs Float195.970Historical High--Div YieldTTM13.40%Amplitude4.620Historical Low5.540Avg Price1Lot Size
Sage Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 337.08%11.87M | 249.80%8.65M | 139.89%7.9M | 1,024.84%86.46M | 2,621.54%77.97M | 56.18%2.72M | 64.82%2.47M | 108.22%3.29M | 21.85%7.69M | 74.48%2.87M |
| Operating revenue | -68.96%843K | -75.61%600K | -48.69%1.69M | 36.01%10.45M | -30.72%1.99M | 56.18%2.72M | 63.89%2.46M | 108.22%3.29M | 21.85%7.69M | 74.48%2.87M |
| Cost of revenue | 483.20%5.28M | 586.34%1.41M | 451.74%1.27M | 165.56%2.16M | 473.43%820K | 391.85%905K | 2.50%205K | -19.58%230K | 47.02%813K | 64.37%143K |
| Gross profit | 264.05%6.59M | 219.39%7.25M | 116.48%6.63M | 1,126.48%84.3M | 2,734.39%77.15M | 16.46%1.81M | 74.40%2.27M | 136.42%3.06M | 19.43%6.87M | 75.05%2.72M |
| Operating expense | -40.13%107.8M | -31.37%118.55M | -21.59%124.31M | 13.88%630.76M | -23.74%119.44M | 25.89%180.06M | 33.13%172.73M | 27.34%158.53M | 18.69%553.86M | 23.29%156.62M |
| Selling and administrative expenses | -31.89%53.22M | -25.91%55.98M | -19.99%52.57M | 20.56%274.52M | -18.15%55.11M | 27.10%78.14M | 36.04%75.57M | 41.38%65.71M | 24.09%227.7M | 30.49%67.33M |
| -General and administrative expense | -31.89%53.22M | -25.91%55.98M | -19.99%52.57M | 20.56%274.52M | -18.15%55.11M | 27.10%78.14M | 36.04%75.57M | 41.38%65.71M | 24.09%227.7M | 30.49%67.33M |
| Research and development costs | -46.45%54.58M | -35.61%62.56M | -22.72%71.73M | 9.22%356.24M | -27.96%64.33M | 24.97%101.92M | 25.70%97.16M | 18.98%92.83M | 15.18%326.16M | 18.36%89.3M |
| Operating profit | 43.22%-101.2M | 34.70%-111.3M | 24.31%-117.68M | 0.10%-546.46M | 72.52%-42.29M | -25.99%-178.25M | -32.71%-170.46M | -26.19%-155.47M | -18.68%-546.99M | -22.64%-153.9M |
| Net non-operating interest income expense | -25.62%7.64M | -17.12%8.43M | 4.24%9.2M | 173.03%38.74M | 39.36%9.47M | 148.95%10.27M | 383.97%10.17M | 655.99%8.83M | 392.20%14.19M | 804.53%6.79M |
| Non-operating interest income | -25.62%7.64M | -17.12%8.43M | 4.24%9.2M | 173.03%38.74M | 39.36%9.47M | 148.95%10.27M | 383.97%10.17M | 655.99%8.83M | 392.20%14.19M | 804.53%6.79M |
| Other net income (expense) | 100.03%9K | 136.59%15K | 93.62%-12K | -225,226.67%-33.77M | 408.11%114K | -112,280.00%-33.65M | -191.11%-41K | -683.33%-188K | -88.81%15K | -254.17%-37K |
| Special income (charges) | --0 | ---- | ---- | ---33.39M | --213K | ---33.6M | ---- | ---- | --0 | --0 |
| -Less：Restructuring and merger&acquisition | --0 | ---- | ---- | --33.39M | ---213K | --33.6M | ---- | ---- | --0 | --0 |
| Other non- operating income (expenses) | 116.36%9K | 136.59%15K | 93.62%-12K | -2,653.33%-383K | -167.57%-99K | -283.33%-55K | -191.11%-41K | -683.33%-188K | -88.81%15K | -254.17%-37K |
| Income before tax | 53.60%-93.55M | 35.85%-102.85M | 26.12%-108.48M | -1.63%-541.49M | 77.77%-32.71M | -46.83%-201.63M | -26.94%-160.33M | -20.30%-146.83M | -16.36%-532.78M | -17.99%-147.15M |
| Income tax | ||||||||||
| Net income | 53.60%-93.55M | 35.85%-102.85M | 26.12%-108.48M | -1.63%-541.49M | 77.77%-32.71M | -46.83%-201.63M | -26.94%-160.33M | -20.30%-146.83M | -16.36%-532.78M | -17.99%-147.15M |
| Net income continuous Operations | 53.60%-93.55M | 35.85%-102.85M | 26.12%-108.48M | -1.63%-541.49M | 77.77%-32.71M | -46.83%-201.63M | -26.94%-160.33M | -20.30%-146.83M | -16.36%-532.78M | -17.99%-147.15M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 53.60%-93.55M | 35.85%-102.85M | 26.12%-108.48M | -1.63%-541.49M | 77.77%-32.71M | -46.83%-201.63M | -26.98%-160.33M | -20.30%-146.83M | -16.36%-532.78M | -17.99%-147.15M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 53.60%-93.55M | 35.85%-102.85M | 26.12%-108.48M | -1.63%-541.49M | 77.77%-32.71M | -46.83%-201.63M | -26.98%-160.33M | -20.30%-146.83M | -16.36%-532.78M | -17.99%-147.15M |
| Basic earnings per share | 54.60%-1.53 | 36.57%-1.7 | 26.83%-1.8 | -0.78%-9.05 | 78.14%-0.54 | -45.89%-3.37 | -25.82%-2.68 | -18.84%-2.46 | -15.13%-8.98 | -16.51%-2.47 |
| Diluted earnings per share | 54.60%-1.53 | 36.57%-1.7 | 26.83%-1.8 | -0.78%-9.05 | 78.14%-0.54 | -45.89%-3.37 | -25.82%-2.68 | -18.84%-2.46 | -15.13%-8.98 | -16.51%-2.47 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
